1 study found for:
NCT00071838
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
|
† Indicates status has not been verified in more than two years
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
|